At a glance

ClinicalIndex Comparison Record

Phase 3Completed

Drug / intervention

aspirindrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000491

NCT00000491Phase 3Completed

Compare CT.gov

Aspirin-Myocardial Infarction Study (AMIS)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Mar 25, 2016

In Brief

A Phase 3 clinical trial evaluating aspirin for Cardiovascular Diseases and 4 related conditions. Completed.

Detailed Summary

To determine whether the daily administration of 1 gm of aspirin to individuals with a documented myocardial infarction would result in a significant reduction in mortality over a three year period.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Infarction, Myocardial Ischemia

Countries--

Collaborators--

Timeline

Phase 3CompletedFinished

197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartOct 1974

Study CompletionAug 1979

First PostedOct 1999

TodayJul 2026

First PostedOct 28, 1999

Enrollment StartOct 1, 1974

Study CompletionAug 1, 1979

TodayJul 2, 2026

Posted 26.7 years ago

Interventions

aspirindrug